Sanofi Releases Half-Year Financial Report for 2026

On July 30, 2026, Sanofi announced the availability of its half-year financial report for the period ending June 30, 2026. The report has been filed with both the French market regulator, Autorité des marchés financiers (AMF), and the US Securities and Exchange Commission (SEC) under form 6-K. The document is accessible online via the Sanofi website, specifically within the "Investors" page under the "Financial Reports and Other Publications" section.

This release highlights Sanofi's commitment to transparency and regulatory compliance, ensuring that stakeholders and investors can access detailed financial information. It reflects the company's emphasis on maintaining clarity in its financial communications amidst its ongoing operations in the pharmaceutical sector.